Position in NVO
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$1,036,079
+$183,443 QoQ
Shares Held
21,612
-6.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.24%
of 13F equity value
Holder Rank
#519
of 1,348 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Claro Advisors Inc. holds $23,719,798 across 11 Drug Manufacturers - General names. NVO ranks #8 (4.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
23,282 | $5,858,682 | |
| 2 | JNJ |
Johnson & Johnson
|
22,661 | $5,755,214 | |
| 3 | LLY |
ELI LILLY & Co
|
3,896 | $4,672,979 | |
| 4 | MRK |
Merck & Co., Inc.
|
11,805 | $1,516,942 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
24,313 | $1,400,915 | |
| 6 | AMGN |
Amgen Inc
|
3,385 | $1,225,776 | |
| 7 | PFE |
Pfizer Inc
|
47,000 | $1,131,760 | |
| 8 | NVO |
Novo Nordisk A S
This page
|
21,612 | $1,036,079 |
All Filings in NVO
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,036,079 | 21,612 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $852,636 | 23,201 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $1,064,358 | 20,919 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $1,166,344 | 21,019 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $1,464,811 | 21,223 | Shares | Sole | 2025-08-05 | |
| 2025-03-31 | $1,484,974 | 21,385 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $1,829,817 | 21,272 | Shares | Sole | 2025-01-13 | |
| 2024-09-30 | $3,106,298 | 26,088 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $3,365,666 | 23,579 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $2,983,759 | 23,238 | Shares | Sole | 2024-04-18 | |
| 2023-12-31 | $2,327,107 | 22,495 | Shares | Sole | 2024-01-22 | |
| 2023-09-30 | $2,044,149 | 22,478 | Shares | Sole | 2023-10-10 | |
| 2023-06-30 | $1,844,214 | 11,396 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $1,799,236 | 11,306 | Shares | Sole | 2023-04-17 | |
| 2022-12-31 | $1,532,725 | 11,325 | Shares | Sole | 2023-03-13 | |
| 2022-09-30 | $1,089,454 | 10,935 | Shares | Sole | 2022-11-18 | |
| 2022-06-30 | $1,218,487 | 10,935 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $1,159,028 | 10,437 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $1,168,944 | 10,437 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $978,533 | 10,192 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $752,589 | 8,984 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $600,442 | 8,906 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $719,594 | 10,302 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $710,130 | 10,228 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $677,783 | 10,351 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $612,294 | 10,171 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||